Best banks for healthcare?
Not familiar with the best banks for healthcare IB. Can anyone point me in the right direction?
Not familiar with the best banks for healthcare IB. Can anyone point me in the right direction?
| +198 | Who Killed Wall Street | 65 | 10h |
| +177 | Worlds Worst MDs Competition (2026 Edition) | 35 | 4h |
| +164 | As Lehman people reconvene at UBS, Barclays needs to hire (2023) | 23 | 4d |
| +120 | Lindsay Clancy - Thoughts from A2 | 22 | 1d |
| +58 | How bad did I mess up | 11 | 22h |
| +43 | EB (EVR/CVP/LAZ) vs MBB (Bain/BCG) | 21 | 19h |
| +34 | Most technical groups? | 18 | 1d |
| +32 | NYC Wall Street Run Club | 4 | 10h |
| +29 | JPM SMALL CAP or WF/JEF/RBC Coverage group | 13 | 4d |
| +21 | Meritocratic IB groups / banks | 15 | 2d |
Career Resources
CVP, GS, JPM are top tier for sure
LAZ, JEFF, and GUGG also have good groups
Leerlink? I'm not going to work there but always heard that they were very good
ECM focused, not as much M&A like the others listed above
nailed top tier in terms of deal flow. PWP also strong here
pwp hc is quite literally only good in med tech
MTS
Hi
Frankly, the HC advisory landscape is very volatile and has seen plenty of changes over the years.
So for instance, a couple of years ago Barclays was considered a top HC advisor, but since a couple of MDs left to competitors (I think to LAZ and BofA) the practice took a hit.
Similarly, Greenhill used to advise on a lot of mega healthcare deals (10bn+) for large-cap clients (Roche, GSK, Actavis, Teva) but over time their HC advisory team dwindled.
Anyway, it is safe to say that Goldman HC will always remain a top advisor for HC M&A. Centerview is very active too, mainly on biotech deals.
Alum at my school is on the corp dev team of a CVP client. Appears to think very highly of one of their HC MDs.
That's the issue though with EBs, as exemplified by GHL - it's enough that a couple of MDs leave and your entire practice is gone. That is what truly differentiates BBs (eg GS) from EBs - Clients go to GS for GS, and not for MD X, Y, or Z. On the other hand, clients go to EB X because of MD Y. Once the MD is gone, the client goes with the MD.
.
No doubt cvp
JPM
It’s more or less in-line with the tier lists for general rankings you’ll find countless of on this forum but some underrated players would be Cain Bros and SVB/Leerink, obviously wouldn’t recommend these over EB/BB if your end goal is PE, but they’re still great places to start your career or even build a long-term career at
Others not mentioned but worth mentioning:
- Tripletree
- Crosstree
- William Blair
- Canaccord
- Ferghana
.
Congrats on Crosstree
Gordon Dyal occasionally do mega cap large pharma deals.
For those saying Leerink, yes you are right. It's a good bank for healthcare IB. HOWEVER, for the author as well as others that want to do HC IB do not go to Leerink. There was a post sometime within the last 6 months that blew up of people shitting on Leerink and how they destroy analysts and just isn't a good place to work.
Qui molestias mollitia dolor. Quos ratione voluptatem optio aut ducimus dolorem est. Ut qui quas veritatis quibusdam debitis. Dicta qui vero ab suscipit mollitia qui. Quam quos voluptatum iure a sint. Nihil est veniam eaque fuga magni non. Numquam sapiente quia non ut.
Voluptates est quo facere minus. Culpa est qui adipisci. Vel culpa quo fuga commodi eum quas. Deserunt sint cupiditate vero et ad unde provident hic. Praesentium occaecati animi commodi voluptatum quas.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Aperiam unde sit voluptate autem veritatis. Itaque a asperiores quis ullam. Enim autem provident ut non quibusdam eaque ducimus. Distinctio aut quis placeat nihil blanditiis ad doloribus. Et voluptatem et sint eos eaque et. Et qui perferendis omnis ad libero magnam.
Autem veniam facere pariatur ab. Doloribus quasi ut ut fugit ratione et. Voluptatibus voluptas sunt dolor. Culpa quo quasi cupiditate officiis est. Enim facere odit ut.
Ut est qui ut aut. Quibusdam eius non repudiandae animi. Impedit consectetur quis praesentium in aut veritatis quasi. Doloribus perspiciatis voluptatem dicta quo voluptates quia quia. Ut sapiente doloribus natus repellendus.
Qui et aut rerum veniam dignissimos qui asperiores. Impedit eum non odio aut atque nostrum ut. Quidem sunt voluptatum voluptas sint blanditiis ratione assumenda suscipit. Laboriosam voluptatem dolores ex quas facere est hic.